Hovnanian Reports Q2 Fiscal 2026 Net Loss, Exceeds Some Guidance, Repurchases $9.5M in Stock, and Issues Q3 Outlook

summarizeSummary

Hovnanian Enterprises reported a net loss for Q2 fiscal 2026 but showed sequential improvement in gross margins, exceeded some guidance metrics, and repurchased $9.5 million in stock, while also issuing Q3 guidance and an optimistic Q4 outlook.

check_boxKey Events

• Q2 Fiscal 2026 Financial Results

  The company reported a net loss of $0.6 million, or $0.46 per diluted common share, on total revenues of $667.6 million for the second quarter ended April 30, 2026. This compares to net income of $19.7 million, or $2.43 per diluted common share, on revenues of $686.5 million in the prior-year period.

• Sequential Margin Improvement

  Homebuilding gross margin percentage, before cost of sales interest expense and land charges, improved sequentially to 14.3% in Q2 fiscal 2026, exceeding the high end of the company's guidance range. This marks a rebound from the first quarter trough.

• Strong Liquidity and Share Repurchases

  Total liquidity as of April 30, 2026, was $442.0 million, significantly above the target range of $170 million to $245 million. The company repurchased 90,507 shares of common stock for $9.5 million at an average price of $104.60 per share during the quarter, continuing an existing program.

• Q3 Fiscal 2026 Guidance Issued

  For the third quarter of fiscal 2026, the company expects total revenues between $650 million and $750 million, adjusted homebuilding gross margin between 14.0% and 15.0%, and adjusted income before income taxes between breakeven and $10 million.

auto_awesomeAnalysis

Hovnanian Enterprises reported a net loss for Q2 fiscal 2026, a decline from the prior year's net income. However, the company demonstrated operational resilience with homebuilding gross margins improving sequentially and exceeding guidance. The company also maintained strong liquidity and executed a significant share repurchase program. The provided Q3 guidance and an optimistic outlook for Q4, anticipating a 'significant step-up' in performance, will be key for investors assessing the company's recovery trajectory.